Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Comparing a single erector spinae block to parasternal plus serratus blocks for pain after sternotomy

Official title: Sternotomi İle Kardiyak Cerrahi Planlanan Hastalarda Postoperatif Sternotomi Ağrısının Yönetiminde Erektör Spina Plan Blok (ESPB) Ile Yüzeyel Parasternal İnterkostal Plan Bloğu (SPIPB) ve Serratus Anterior Plan Bloğu (SAPB) Kombinasyonunun Karşılaştırılması

Run by Uludag University · NCT07472296 · Data updated 2026-11-12

We will see if a single erector spinae nerve block or a combination of superficial parasternal and serratus anterior blocks better controls pain and reduces opioid use in adults having elective open‑chest (sternotomy) heart surgery.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment50 (estimated)
SponsorUludag University
Academic / other
Locations1 site (Bursa, Nilüfer)
StatusRecruiting
StartedNovember 1, 2025
Main results expectedOctober 2026
Study endsNovember 2026
Registry record updatedMarch 16, 2026
Trial IDNCT07472296 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 with ASA physical status I–III who are scheduled for elective cardiac surgery via median sternotomy and can give informed consent are ideal candidates.

Probably not a fit

Patients having emergency or redo cardiac surgery, with BMI over 35, coagulopathy, infection at the injection site, allergy to local anesthetics, or severe organ failure are unlikely to be eligible or to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional study will enroll 50 adults (ages 18–80, ASA I–III) scheduled for elective cardiac surgery via median sternotomy and assign them before anesthesia to either an erector spinae plane block (ESPB) or a combined superficial parasternal intercostal plane block (SPIPB) plus serratus anterior plane block (SAPB). Nerve blocks are performed prior to induction of general anesthesia and standard intraoperative and postoperative care follows. Outcomes include pain scores at rest and with coughing (VAS), intraoperative opioid use, behavioral pain scores after surgery, extubation times, and time to first rescue analgesic. The protocol compares analgesic efficacy and opioid-sparing effects between the two regional anesthesia approaches.

Why it matters

Potential benefit: If successful, the better block strategy could reduce postoperative sternotomy pain, lower opioid requirements, and speed early recovery after cardiac surgery.

How similar studies have gone: Related regional blocks such as ESPB, SAPB, and parasternal blocks have shown promise in reducing thoracic and poststernotomy pain and opioid use, but direct head‑to‑head comparisons of ESPB versus the combined SPIPB+SAPB approach are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged between 18 and 80 years.
* Patients classified as American Society of Anesthesiologists (ASA) physical status I, II, or III.
* Patients scheduled for elective cardiac surgery via median sternotomy.
* Patients who have provided written informed consent.

Exclusion Criteria:

* Pregnancy or suspected pregnancy.
* Body Mass Index (BMI) \> 35 kg/m².
* Known allergy or hypersensitivity to local anesthetics (e.g., bupivacaine).
* Suspected coagulopathy or bleeding disorders.
* Infection at the site of the regional block injection.
* Severe hepatic or renal failure.
* Severe neurological or psychiatric disorders.
* Emergency surgical procedures.
* Re-operation cases (Redo-surgery)

Where it's running

  • Bursa Uludag University Hospital
    Bursa, Nilüfer, Turkey (Türkiye)
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.